Astera Labs, Inc. $ALAB Shares Purchased by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC boosted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 254.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 238,777 shares of the company’s stock after buying an additional 171,354 shares during the period. Stephens Investment Management Group LLC’s holdings in Astera Labs were worth $39,723,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after buying an additional 84,365 shares during the last quarter. State Street Corp boosted its stake in Astera Labs by 9.1% in the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock worth $458,065,000 after buying an additional 195,992 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Astera Labs by 46.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after buying an additional 479,360 shares during the last quarter. Amundi boosted its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Finally, Value Aligned Research Advisors LLC boosted its stake in Astera Labs by 16.7% in the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after buying an additional 197,320 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Weiss Ratings raised Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. UBS Group assumed coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Jefferies Financial Group restated a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Needham & Company LLC raised their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Fifteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $229.65.

Astera Labs Price Performance

Astera Labs stock opened at $232.68 on Friday. The company has a market cap of $39.88 billion, a price-to-earnings ratio of 157.22, a price-to-earnings-growth ratio of 3.08 and a beta of 3.35. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $262.90. The stock’s 50-day moving average is $155.40 and its 200-day moving average is $156.41.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% on a year-over-year basis. During the same period last year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 139,951 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the sale, the chief executive officer directly owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. This trade represents a 3.44% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 230,639 shares of the firm’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $198.22, for a total value of $45,717,262.58. Following the sale, the chief operating officer owned 664,361 shares in the company, valued at approximately $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,497,338 shares of company stock worth $236,827,957. 12.50% of the stock is currently owned by company insiders.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
• Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
• Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.